Immix Biopharma Inc (IMMX) concluded trading on Thursday at a closing price of $2.41, with 3.7 million shares of worth about $8.91 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 42.60% during that period and on May 22, 2025 the price saw a gain of about 15.31%. Currently the company’s common shares owned by public are about 27.85M shares, out of which, 16.60M shares are available for trading.
Stock saw a price change of 15.31% in past 5 days and over the past one month there was a price change of 40.94%. Year-to-date (YTD), IMMX shares are showing a performance of 9.55% which decreased to -4.37% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.26 but also hit the highest price of $2.71 during that period. The average intraday trading volume for Immix Biopharma Inc shares is 54.47K. The stock is currently trading 16.62% above its 20-day simple moving average (SMA20), while that difference is up 31.65% for SMA50 and it goes to 28.85% higher than SMA200.
Immix Biopharma Inc (NASDAQ: IMMX) currently have 27.85M outstanding shares and institutions hold larger chunk of about 10.92% of that.
The stock has a current market capitalization of $67.18M and its 3Y-monthly beta is at 0.24. It has posted earnings per share of -$0.72 in the same period. It has Quick Ratio of 1.80 while making debt-to-equity ratio of 0.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IMMX, volatility over the week remained 7.03% while standing at 4.78% over the month.
Stock’s fiscal year EPS is expected to rise by 13.64% while it is estimated to decrease by -52.63% in next year.
